At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 9, 2026 at 18:06 ET
Three top insiders at United Therapeutics, the CEO, CFO, and General Counsel, executed a cluster of open-market sales totaling ~$1.76M over a 7-day window. All sales were part of a coordinated pattern of option exercises and same-day share dispositions, consistent with routine tax-related selling rather than a bearish signal. The total value represents ~0.008% of the company's $23.1B market cap, well below the materiality threshold.
- CEO Martine Rothblatt sold 1,462 shares at ~$544.89 on June 8, netting ~$797K
- CFO James Edgemond sold 1,565 shares at ~$544.93 on June 8, netting ~$853K
- EVP Paul Mahon sold 200 shares at ~$539.76 on June 4, netting ~$108K
- All sales were preceded by same-day option exercises at $0 or $117.76–$146.03 strike prices
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access